Thread by @KirstiMiller30

This is what happens in 3 years of meeting IOC policy for a trans woman athlete looks like in real life & not what it looks like in flawed studies of non-athletes like Wiik et al @RogerPielkeJr

HYPOGONADISM & THE BIOLOGICAL HEALTH IMPACTS XY TRANSGENDER FEMALE (NON-SURGICAL)  
Hypogonadism another term for abnormally low testosterone production in the gonads (T<10nmol) and concomitant symptoms suggesting androgen deficiency.

Transgender women retain their gonads and endocrine system undisrupted
while utilizing androgen blockers to reduce testicle production of testosterone. ecreases in patient quality of life long-term.

Common physiologial contraindications: sexual and mental health, muscle atrophy, decrease overall physical strength, increase in subcutaneous fat levels, acclerated bone loss and premature abnormal aging,

large drop in hematocrite levels, cardio vascular health, decreasing primary endocrine function, permanent androgen receptor atrophy, increased vulnerability to coronary heart disease, prone to joint health and injuries,

elevated insulin levels and insulin resistence, elevated core body temperature during exercise, reduced stamina, fatigue, delayed recovery, lethargy and diabetes.

Assessing any group of athletes as a monolithic group especially amongst trans athletes is flawed. Trans is an umbrella term many different body types & stages of transition. Blanket inclusion or exclusion does not work.

ANDROGEN DEPRIVATION BIOLOGICAL HEALTH IMPACTS XY TRANS FEMALE (POST OPERATIVE)”
Complete androgen deprivation is another term for non-existent production of the sole primary hormone required testosterone, due to a bilateral orchiectomy (removal of the gonads) to create the vulva

Though XY chromosomes, requires testosterone levels to be (T>14nmol or higher) to be healthy and relieved of symptoms of complete androgen deficiency.

Transitioned women, do not retain gonads responsible for hormone production, the circulation and communications loop of the endocrine system is disrupted, organs, glands are no longer linked and are acting independently on their own.

The symptoms of CAD result in decreases in patient quality of life long-term.  Common physiologial contraindications: loss of sexual and mental health, complete muscle atrophy, increase in subcutaneous fat levels, acclerated bone loss,

premature abnormal aging, large drop in hematocrite levels, cardio vascular health, ceasing of primary endocrine function and protein|androgen synthesis, permanent androgen receptor atrophy,

increased vulnerability to coronary heart disease, prone to joint health and injuries, elevated insulin levels and insulin resistence, elevated core body temperature during exercise, reduced stamina, delayed recovery, lethargy & diabetes.

I talk to @JMcKMelbourne about my work with @Hogshead3Au & Martina Navratilova's policy working group, my journey with testosterone we also talk she about Caster Semenya in Athletics and World Rugby's trans women ban.
3cr.org.au/inyaface/episo…